The Facts31 Oct 2023 22:32
I'll whisper this as the resident trolls and shortes wont like it....
#Hemo Share price and mCAp up SIGNIFICANTLY YOY ; SP i +40%, mCap +60%.
Anyone who invest in 2022 is enjoying those kind of returns
Pretty confident that puts #HEMO in the upper quartile of equity investments over the same period
Just think where the SP would be if:
The FDA did not invoke a clinical hold.... (We'll find out soon when it is lifted)
or
If we'd had an update on CBR (The last one was the catalyst for a 200% rise in the share price)
Hemo's opex has increased significantly in FY23 - as you would expect when preparing IND and about to embark on clincial trials. This increase in cash burn, combined with the clinical hold will also have held back the rise in SP. However, I'm as confident as I can be that Hemo will not be raising a a lower price than the most recent raise in January a@2.5p.
Our new committed, strategic investor has invested at 6p after completing a comprehensive, rigorous duel diligence process. They are now 'banging the drum' for #HEMO and I'm optimistic that other like minded investors will follow their lead.
The trolls can say what they like - it's all rubbish, lies and manipulation.
I choose to go by the RNS and put my confidence in the like of Prevail Parnters (The experts in Biotech investment) over and above a collection of abusive, manipulative keyboard warriors hiding behind multiple alias.
To all those invested - I say good luck
For all those looking for a great Risk / Reward play - I say, do you own research and check us out